share_log

Theratechnologies Analyst Ratings

Benzinga ·  Jul 17, 2023 11:17
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/17/2023 259.97% JonesTrading $6 → $3 Maintains Buy
07/13/2023 979.91% Cantor Fitzgerald → $9 Reiterates Overweight → Overweight
07/03/2023 139.98% Canaccord Genuity → $2 Assumes → Hold
11/17/2022 979.91% Cantor Fitzgerald → $9 Initiates Coverage On → Overweight
07/29/2021 259.97% Canaccord Genuity $8 → $3 Downgrades Buy → Hold
04/19/2021 859.92% Canaccord Genuity $7 → $8 Maintains Buy
04/15/2020 1219.89% Canaccord Genuity $12 → $11 Maintains Buy
12/11/2019 Mackie Research Upgrades Hold → Buy

What is the target price for Theratechnologies (THTX)?

The latest price target for Theratechnologies (NASDAQ: THTX) was reported by JonesTrading on July 17, 2023. The analyst firm set a price target for $3.00 expecting THTX to rise to within 12 months (a possible 259.97% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Theratechnologies (THTX)?

The latest analyst rating for Theratechnologies (NASDAQ: THTX) was provided by JonesTrading, and Theratechnologies maintained their buy rating.

When is the next analyst rating going to be posted or updated for Theratechnologies (THTX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.

Is the Analyst Rating Theratechnologies (THTX) correct?

While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a maintained with a price target of $6.00 to $3.00. The current price Theratechnologies (THTX) is trading at is $0.83, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment